Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica

Multiple Sclerosis Journal

Volumn 19, Issue 2, 2013, Pages 173-178

  Neto, Silvio P ^a,c   Alvarenga, Regina M P ^a,b   Vasconcelos, Claudia C F ^a   Alvarenga, Marina P ^a,b   Pinto, Luiz C ^c   Pinto, Vera L R ^c  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DA LAGOA   (Brazil)

^c Clínica de Eletrodiagnóstico Luiz Carlos Pinto   (Brazil)

Author keywords

differential diagnosis; Multiple sclerosis; neuromyelitis optica; optic neuritis; pattern reversal; visual evoked potential

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PROTEIN P100;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; VISUAL ACUITY; VISUAL STIMULATION;

EID: 84873620677     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512447597     Document Type: Article

References (25)

1. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996 ; 60: 382-387
2. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999 ; 53: 1107-1114
3. Papais-Alvarenga RM, Santos CMM, Almeida AMV, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry. 2002 ; 73: 429-435
4. De Seze J, Stojkovic T, Ferriby D, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002 ; 197: 57-61
5. De Seze J. Neuromyelitis optica. Arch Neurol. 2003 ; 60: 1336-1338
6. De Seze J, Lebrun C, Stojkovic T, et al. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler. 2003 ; 9: 521-525
7. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112
8. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
9. Wingerchuk DM. Neuromyelitis optica. Inter MS J. 2006 ; 13: 42-50
10. Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008 ; 65: 78-83
11. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 ; 63: 390-396
12. Papais-Alvarenga M, Alves-Leon SV, Papais-Alvarenga RM Esclerosis Múltiple - Una Mirada Ibero-Panamericana. 2 nd ed.New York: DEMOS Medical Publishing, 2008, pp.461-472. ISBN 13.978-1-933864-39-6. Camilo Arriagada R Nogales-Gaete Jorge, ed. New York: DEMOS Medical Publishing ; 2008: 461-472.
13. Weinshenker BG. Neuromyelitis optica: what it is and what it might be. Lancet. 2003 ; 361: 889-890
14. Weinshenker BG. Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol. 2007 ; 64: 899-901
15. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
16. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet. 1972 ; 7758: 982-985
17. ColeJL. Equipment parameter determinants in evoked potentials studies. American Society for Clinical Evoked Potentials Bulletin1984; 300-309. http://trove.nla.gov.au/work/34025234
18. Chiappa KH Evoked potentials in clinical medicine. 3 rd ed.Philadelphia: Lippincott-Raven, 1997, pp. 31-146. Philadelphia: Lippincott-Raven ; 1997: 31-146.
19. Pinto LC Neurofisiologia clínica: princípios básicos e aplicações. 2 nd ed.São Paulo: Atheneu, 2010, pp. 359-374. São Paulo: Atheneu ; 2010: 359-374.
20. Frohman EM, Kerr D. Is neuromyelitis optica distinct from multiple sclerosis? Something for 'lumpers' and 'splitters'. Arch Neurol. 2007 ; 64: 903-905
21. Halliday AM, McDonald WI, Mushin J. Visual evoked response in diagnosis of multiple sclerosis. Br Med J. 1973 ; 4: 661-664
22. Matthews WB, Small DG, Small M, et al. Pattern reversal evoked visual potential in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1977 ; 40: 1009-1014
23. Niklas A, Sebraoui H, Hess E, et al. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency. Mult Scler. 2009 ; 15: 68-74
24. Andrade EP, Sacai PY, Berezovsky A, et al. Alterações encontradas no potencial visual evocado por padrão reverso em pacientes com esclerose múltipla definida. Arq Bras Oftalmol. 2007 ; 70: 943-948
25. Watanabe A, Matsushita T, Doi H, et al. Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients. J Neurol Sci. 2009 ; 281: 34-40